Advertisement
For patients with suspected angina due to coronary heart disease

ACC: CTCA Alters Diagnosis, Management in Suspected Angina

0
CTCA alters diagnosis, testing, tx for patients with suspected angina due to coronary heart disease
Evolocumab and alirocumab

ACC: PCSK9 Inhibitors Reduce LDL Cholesterol in Long Term

0
Two studies show reductions in LDL cholesterol with evolocumab and alirocumab
For patients with hypertension

ACC: Enalapril + Folic Acid Cuts Stroke Risk in Hypertension

0
Study in Chinese population shows reduced risk of first stroke with combined use of enalapril, folic acid
Medical specialties vary by gender

Gender-Specific Variation in Medical Specialties

0
About 85 percent of ob-gyn residents are female, while more males in surgery, emergency medicine
Your voice may be the key to landing a new job

Getting Heard May Be Key to Getting New Job

0
Pitch for job was more convincing when evaluators heard it than when they read it
The U.S. Department of Health and Human Services is listening to physicians and wants to address the regulatory burdens they face

HHS Wants to Help Restore Joy of Medicine

0
Agency listening to physicians and addressing concerns including EHR usability, meaningful use
Researchers are not promptly reporting the results of clinical trials to ClinicalTrials.gov

Clinical Trial Data Often Not Reported in Timely Manner

0
Delays in filing findings on new treatments mean patients aren't informed, researcher says
There's yet another study looking at the potential dangers of hormone replacement therapy for menopausal symptoms

More Support for ‘Timing Hypothesis’ in HRT Use

0
No cardiovascular disease protective effect seen
For patients suspected of having hemodynamically significant coronary stenosis

Exercise Perfusion CT Imaging IDs Coronary Stenosis

0
Imaging is feasible and accurate for identifying hemodynamically significant coronary stenosis
For men with prostate cancer

CVD Risk Up With Androgen Deprivation Tx in Prostate Cancer

0
Highest risk during first 6 months of ADT among men who had ≥2 cardiovascular events before tx